Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Conditions
- HIV
- Infant Exposure to Efavirenz
Sponsor
University of North Carolina, Chapel Hill
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]